According to the report drafted by Dr. Zimmermann & Partners the owner of the benefiting company would inject new capital but it was unclear whether this was done.
Dr. Zimmermann & Partneri raporti kohaselt pidi omanik investeerima ettevõttesse uut kapitali, kuid ei ole selge, kas seda ka tegelikult tehti.